Molecular mechanism of the spider toxin κ-LhTx-I acting on the bacterial voltage-gated sodium channel NaChBac

Zhen Xiao, Yaqi Li, Piao Zhao, Xiangyue Wu, Guoqing Luo, Shuijiao Peng, Hongrong Liu, Cheng Tang, Zhonghua LiuFrontiers in Pharmacology 2022 · DOI

Abstract

The bacterial sodium channel NaChBac serves as a simplified prokaryotic prototype for complex eukaryotic $Na_V$ and $Ca_V$ channels. Despite its importance in studying structure-function relationships, few pharmacological modulators for NaChBac have been identified. This study characterizes the spider toxin κ-LhTx-1 as a potent inhibitor of NaChBac ($IC_{50} = 491.0 \pm 61.7$ nM). We demonstrate that κ-LhTx-1 acts by impeding voltage-sensor activation, a mechanism similar to mammalian $Na_V$ site 4 toxins. Mutagenesis and molecular docking identify a critical hydrophobic interaction between toxin residue W27 and channel residue F103. These findings establish κ-LhTx-1 as a valuable tool for investigating toxin-channel interactions in native membrane environments.

Introduction

Voltage-gated sodium ($Na_V$) channels are fundamental to electrical signaling in excitable cells. Due to the structural complexity of mammalian $Na_V$ channels, researchers frequently utilize the bacterial channel NaChBac as a model system. However, the limited availability of specific ligands for NaChBac has hindered detailed pharmacological studies. This research identifies κ-LhTx-1, a spider toxin previously known to target $K_V4$ potassium channels, as a potent and selective modulator of NaChBac.

Methods

The study utilized whole-cell patch-clamp electrophysiology in HEK293T and CHO-K1 cells to quantify the inhibitory effects of κ-LhTx-1. Site-directed mutagenesis (alanine scanning) was performed on the NaChBac S3-S4 extracellular loop to identify binding determinants. Computational modeling, including C-I-TASSER for structure prediction and ZDOCK for molecular docking, was used to simulate the toxin-channel interface, drawing on structural templates from the Protein Data Bank (PDB IDs: 6VWX, 7K48, and 1LUP).

Key Results

κ-LhTx-1 exhibited high potency against NaChBac, with an $IC_{50}$ of approximately 491 nM. Electrophysiological analysis revealed that the toxin shifts the conductance-voltage ($G–V$) curve to more positive potentials, indicating a "voltage-sensor trapping" mechanism. This means the toxin binds to the voltage-sensing domain (VSD) and prevents its outward movement, keeping the channel closed.

κ-LhTx-1 potently inhibits NaChBac current. (A) Sequence alignment of κ-LhTx-1 with related toxins. (B) Representative NaChBac current traces showing dose-dependent inhibition. (C) Lack of effect on the NaVPZ channel. (D) Dose-response curve for NaChBac inhibition. (E) Time course of inhibition and subsequent recovery after washout.

Mutagenesis experiments highlighted the importance of residue F103 in the S3-S4 loop of NaChBac. Replacing F103 with alanine significantly reduced the toxin's efficacy. Conversely, introducing a phenylalanine into the toxin-resistant $Na_VPZ$ channel (P92F mutation) conferred sensitivity to κ-LhTx-1, confirming F103 as a primary interaction site.

Discussion and Insights

The discovery that κ-LhTx-1 targets both $K_V4$ and NaChBac suggests a high degree of structural conservation in the VSDs across different ion channel families. The interaction is primarily driven by a hydrophobic anchor: toxin residue W27 stacks against channel residue F103.

Notably, κ-LhTx-1 showed minimal activity against most mammalian $Na_V$ subtypes at concentrations up to 10 μM, with the exception of moderate inhibition of $Na_V1.7$. This selectivity makes κ-LhTx-1 an excellent probe for studying bacterial channel models without significant interference from mammalian channel activity. Given that NaChBac has been successfully incorporated into nanodiscs, κ-LhTx-1 provides a unique opportunity to study these interactions within a lipid bilayer environment, potentially leading to more accurate structural models of channel modulation.

Summary updated

Abstract

The bacterial sodium channel NaChBac is the prokaryotic prototype for the eukaryotic Na<sub>V</sub> and Ca<sub>V</sub> channels, which could be used as a relatively simple model to study their structure-function relationships. However, few modulators of NaChBac have been reported thus far, and the pharmacology of NaChBac remains to be investigated. In the present study, we show that the spider toxin κ-LhTx-1, an antagonist of the K<sub>V</sub>4 family potassium channels, potently inhibits NaChBac with an IC<sub>50</sub> of 491.0 ± 61.7 nM. Kinetics analysis revealed that κ-LhTx-1 inhibits NaChBac by impeding the voltage-sensor activation. Site-directed mutagenesis confirmed that phenylalanine-103 (F103) in the S3-S4 extracellular loop of NaChBac was critical for interacting with κ-LhTx-1. Molecular docking predicts the binding interface between κ-LhTx-1 and NaChBac and highlights a dominant hydrophobic interaction between W27 in κ-LhTx-1 and F103 in NaChBac that stabilizes the interface. In contrast, κ-LhTx-1 showed weak activity on the mammalian Na<sub>V</sub> channels, with 10 µM toxin slightly inhibiting the peak currents of Na<sub>V</sub>1.2-1.9 subtypes. Taken together, our study shows that κ-LhTx-1 inhibits the bacterial sodium channel, NaChBac, using a voltage-sensor trapping mechanism similar to mammalian Na<sub>V</sub> site 4 toxins. κ-LhTx-1 could be used as a ligand to study the toxin-channel interactions in the native membrane environments, given that the NaChBac structure was successfully resolved in a nanodisc.
BibTeX
@inproceedings{xiao2022molecular,
  author = {Zhen Xiao and Yaqi Li and Piao Zhao and Xiangyue Wu and Guoqing Luo and Shuijiao Peng and Hongrong Liu and Cheng Tang and Zhonghua Liu},
  title = {{Molecular mechanism of the spider toxin κ-LhTx-I acting on the bacterial voltage-gated sodium channel NaChBac}},
  booktitle = {Frontiers in Pharmacology},
  year = {2022},
  doi = {10.3389/fphar.2022.924661},
}
Figure